Revolutionizing genetic disease treatment: The case of exagamglogene autotemcel

被引：0
|
作者：
Rao, Shuquan [1 ]
Yao, Yao [1 ]
Huo, Wenxuan [2 ,3 ]
Cao, Yang [4 ,5 ]
Budde, Lihua E. [6 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China
[2] Peking Univ Peoples Hosp, Peking Univ Inst Hematol, Natl Clin Res Ctr Hematol Dis, Beijing 100044, Peoples R China
[3] Chinese Acad Med Sci 2019RU029, Key Tech Diag & Treatments Hematol Malignancies, Res Unit, Beijing 100044, Peoples R China
[4] Huazhong Univ Sci & Technol, Dept Hematol, Wuhan 430030, Peoples R China
[5] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Canc Biol Res Ctr, Wuhan 430030, Peoples R China
[6] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Stem Cell Transplantat, Duarte, CA 91010 USA
来源：
INNOVATION | 2024年 / 5卷 / 03期
关键词：
D O I：
10.1016/j.xinn.2024.100619
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Health-Related Quality-of-Life Improvements after Exagamglogene Autotemcel in Patients with Severe Sickle Cell Disease
    Sharma, Akshay
    Frangoul, Haydar
    Locatelli, Franco
    Kuo, Kevin H. M.
    Bhatia, Monica
    Mapara, Markus Y.
    Eckrich, Michael J.
    Imren, Suzan
    Li, Nanxin
    Rubin, Jaime
    Zhang, Siyu
    Liu, Tina
    Hobbs, William
    Grupp, Stephan A.
    BLOOD, 2024, 144 : 7453 - 7454
  • [22] Revolutionizing genetic disease treatment: Recent technological advances in base editing
    Daniel, Tyler C.
    Zeng, Hongzhi
    Osikpa, Emmanuel C.
    Gao, Xue
    CURRENT OPINION IN BIOMEDICAL ENGINEERING, 2023, 28
  • [23] MODEL-PROJECTED CLINICAL OUTCOMES OF EXAGAMGLOGENE AUTOTEMCEL (EXA-CEL) IN PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASOOCCLUSIVE CRISES IN CANADA
    Udeze, C.
    Gargano, M.
    Kaindl, L.
    Kane, S.
    Zhou, A.
    Jain, S.
    Lopez, A.
    VALUE IN HEALTH, 2024, 27 (12)
  • [24] ECONOMIC EVALUATION OF EXAGAMGLOGENE AUTOTEMCEL (EXA-CEL) GENE-EDITED THERAPY IN PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES
    Udeze, C.
    Xie, Y.
    Ogunsile, F. J.
    Mujumdar, U.
    Yang, H.
    Chen, X.
    Jeyakumar, S.
    Li, N.
    Wang, J.
    Lopez, A.
    VALUE IN HEALTH, 2023, 26 (06) : S91 - S91
  • [25] European Hematology Association 2024: Presentation of positive Long-Term Data on Exagamglogene autotemcel in SCD and TDT
    不详
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2024, 51 (05)
  • [26] Improvements in Health-Related Quality of Life after Exagamglogene Autotemcel in Patients with Transfusion-Dependent Beta-Thalassemia
    Locatelli, Franco
    Lang, Peter
    Corbacioglu, Selim
    Wall, Donna
    Li, Amanda M.
    de La Fuente, Josu
    Kohli, Puja
    Li, Nanxin
    Rubin, Jaime
    Zhang, Siyu
    Zhang, Lanju
    Hobbs, William
    Frangoul, Haydar
    BLOOD, 2023, 142
  • [27] Revolutionizing genetic diagnostics: Innovative techniques for inherited disease detection
    Dwivedi, Shradha Devi
    Yadav, Sachin Dev
    Sahu, Divya
    Singh, Deependra
    Singh, Manju Rawat
    GENE REPORTS, 2024, 36
  • [28] ECONOMIC EVALUATION OF EXAGAMGLOGENE AUTOTEMCEL (EXA-CEL) GENE-EDITED THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT BETA-THALASSEMIA
    Udeze, C.
    Fang, H.
    Ogunsile, F. J.
    Mujumdar, U.
    Nie, X.
    Yang, H.
    Jeyakumar, S.
    Li, N.
    Zhao, J.
    Lopez, A.
    VALUE IN HEALTH, 2023, 26 (06) : S1 - S1
  • [29] Health-Related Quality-of-Life Improvements after Exagamglogene Autotemcel in Patients with Transfusion-Dependent Beta-Thalassemia
    de la Fuente, Josu
    Locatelli, Franco
    Lang, Peter
    Meisel, Roland
    Wall, Donna
    Corbacioglu, Selim
    Li, Amanda M.
    Shah, Ami J.
    Mapara, Markus Y.
    Liem, Robert I.
    Merkeley, Hayley Lynne
    Kuo, Kevin H. M.
    Rupprecht, Joachim
    Kohli, Puja
    Li, Nanxin
    Rubin, Jaime
    Zhang, Siyu
    Liu, Tina
    Hobbs, William
    Frangoul, Haydar
    BLOOD, 2024, 144 : 7454 - 7455
  • [30] Betibeglogene autotemcel/busulfanVarious toxicities: case report
    Reactions Weekly, 2021, 1868 (1) : 112 - 112
12345